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Abstract
Cognitive impairment in Alzheimer’s disease (AD) patients is associated with a decline in the levels of growth factors,
impairment of axonal transport and marked degeneration of basal forebrain cholinergic neurons (BFCNs). Neurogenesis
persists in the adult human brain, and the stimulation of regenerative processes in the CNS is an attractive prospect for
neuroreplacement therapy in neurodegenerative diseases such as AD. Currently, it is still not clear how the
pathophysiological environment in the AD brain affects stem cell biology. Previous studies investigating the effects of
the b-amyloid (Ab) peptide on neurogenesis have been inconclusive, since both neurogenic and neurotoxic effects on
progenitor cell populations have been reported. In this study, we treated pluripotent human embryonic stem (hES) cells
with nerve growth factor (NGF) as well as with fibrillar and oligomeric Ab1-40 and Ab1-42 (nM-mM concentrations) and
thereafter studied the differentiation in vitro during 28-35 days. The process applied real time quantitative PCR,
immunocytochemistry as well as functional studies of intracellular calcium signaling. Treatment with NGF promoted the
differentiation into functionally mature BFCNs. In comparison to untreated cells, oligomeric Ab1–40 increased the number of
functional neurons, whereas oligomeric Ab1–42 suppressed the number of functional neurons. Interestingly, oligomeric Ab
exposure did not influence the number of hES cell-derived neurons compared with untreated cells, while in contrast fibrillar
Ab1–40 and Ab1–42 induced gliogenesis. These findings indicate that Ab1–42 oligomers may impair the function of stem cell-
derived neurons. We propose that it may be possible for future AD therapies to promote the maturation of functional stem
cell-derived neurons by altering the brain microenvironment with trophic support and by targeting different aggregation
forms of Ab.
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Introduction
Neurogenesis is thought to persist in the adult mammalian brain
[1], but declines during ageing and is insufficient in preventing the
neuronal loss that occurs in neurodegenerative disorders, such as
Alzheimer’s disease (AD). In AD, there is a marked reduction of
basal forebrain cholinergic neurons (BFCNs), which correlates
with the memory impairment and cognitive dysfunction observed
in AD patients [2]. Nerve growth factor (NGF), a member of the
neurotrophin family, promotes the survival of BFCNs by acting on
their high affinity tyrosine kinase receptors (TrkAs) [3]. During the
progression of the disease, NGF levels in the brain decrease as a
result of dysmetabolism and impaired axonal transport [4,5]. It
has also been hypothesized that a diminished conversion of the
precursor form of NGF (proNGF) to mature NGF, as well as
augmented degradation of the mature form, could underlie the
cholinergic atrophy observed in the AD brain [6].
The accumulation of b-amyloid (Ab) plaques is a key feature in
the brains of AD patients and implicated in the disruption of
normal cellular processes leading to neurodegeneration [7].
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aggregation forms, ranging from dimers and oligomers to fibrils in
amyloid plaques. However, the magnitude of amyloid plaque
deposition in the brain correlates poorly with cognitive decline,
and emerging evidence suggests that Ab oligomers may be the
major culprits in this regard [8]. Functional studies have
demonstrated that oligomeric Ab species can impair long-term
potentiation (LTP) and synaptic function in mature neurons [9].
Although neuronal loss is persistent in AD, an increased
hippocampal neurogenesis has been reported in AD post mortem
brain [10]. This exciting finding has reinforced the expectation
that stimulating regenerative processes and cell survival in the
brain may be clinically beneficial as a novel treatment approach
for AD. Pluripotent human embryonic stem (hES) cells represent a
rich source of expandable cells that can be used for generating
various cell populations, including neurons. A concern regarding
the therapeutic value of stem cells is identifying the conditions in
vivo under which these cells differentiate into a specific lineage, and
to develop reliable and reproducible protocols that would
efficiently produce functionally mature neurons derived from stem
cells.
In an earlier report, we showed that hES cells differentiate into
neurons in feeder-free and serum-free conditions [11]. We have
also recently established an optimized embryoid bodies based
protocol that can generate neurons expressing functional cholin-
ergic receptors following growth factor treatment [12]. Few studies
to date have investigated the effects of Ab on stem cell proliferation
and differentiation and the existing data remains inconclusive
[13,14,15,16,17]. Systematic studies investigating how fibrillar
and oligomeric forms of Ab influence the differentiation and
functionality of human stem cells are therefore important.
In the present study, we treated hES cells with NGF to promote
the differentiation into BFCNs. Furthermore, we examined the
influence of fibrillar and oligomeric Ab1–40 and Ab1–42 on hES cell
proliferation, cell survival signaling pathways and neuronal
differentiation as well as the effects on cytosolic calcium [Ca
2+]i.
Materials and Methods
Ethics statement
The lines HS293 and HS346 were previously derived from fresh
poor quality embryos that had been donated for research in the
Fertility Unit of the Karolinska University Hospital, Huddinge,
Sweden. An informed consent form was signed by both partners
after receiving an oral and written description of the study. The
Ethics Board of the Karolinska Institutet approved the derivation
and research use of these lines.
Human embryonic stem cell culture
Two fully characterized hES cell lines, HS293 and HS346, were
used in this study. Both lines have been derived from donated
supernumerary blastocyst stage embryos with approval from the
Ethics Board at the Karolinska Institutet, Sweden. Their derivation
hasbeen described indetailpreviously [18,19,20,21,22].These lines
have been accepted for use in the European Union (EU) projects by
the European Commission, which accepted them for the integrated
project ESTOOLS (www.estools.eu). They are also included in the
EU Human Embryonic Stem Cell Registry (www.hESCreg.eu).
The cell lines express pluripotency markers as described in the
above-mentioned and other articles in our publications. Both lines
express Oct 3/4, Nanog, SSEA3 and 4, Tra-1-81, Tra-1-60, and
alkaline phosphatase. These hES lines have remained chromosom-
allystableuptohighpassage,.100,HS293hasa karyotype46,XY
and HS346 46, XX. When injected into immune deficient animals,
they form teratomas, which contain components of all three germ
layers. Figure S1 shows a panel of these characterization results
(Figure S1). Both lines have also been gene expression profiled by
Affymetrix human gene chip 133, microarray and by single
nucleotide polymorphism array (Affymetrix 60).
HS293 and HS346 were grown on human foreskin fibroblasts,
and colonies of cells were subsequently removed from the feeder
layer and the culture was expanded at 37uC in a 5% CO2
humidified incubation chamber in serum-free DMEM/F12+
glutamax medium supplemented with B27 (1:50) heparin (5 mg/
ml), antibiotic-antimycotic mixture (1:100) and EGF + bFGF
(20 ng/ml each, Sigma, St. Louis, MO, USA). The cells were
propagated as free-floating neurospheres and mechanically
passaged every 2–3 weeks. The lines expressed neural lineage
markers nestin, Sox1, and Pax6 when differentiated either as
spheres or in adherent culture for seven days, and two weeks later
vimentin, BLBP, GLAST, and GFAP as reported earlier [11]. For
the in vitro differentiation experiments, neurospheres were plated in
6-well tissue culture plates following a stepwise protocol: culture in
neuronal induction medium (NIM) consisting of DMEM/F12+
glutamax: Neurobasal medium, B27 (without vitamin A; 1:50) and
N2 supplement (1:100) for 4 days. From day 4, the cells that
adhered to the tissue wells were allowed to continue differentiation
for another 18–35 days in neural proliferation medium (NPM)
consisting of DMEM/F12+ glutamax: Neurobasal medium, N2
supplement (1:200), B27 (1:100) and bFGF (20 ng/ml). During
differentiation, the media was replaced twice every week, and the
cells were treated with NGF (50 ng/ml) or oligomeric (rPeptide,
Bogart, GA, USA) and fibrillar (Sigma, St. Louis, MO, USA) Ab1–
40 and Ab1–42 (100 nM, 1 mMo r5mM). All media and cell culture
reagents were purchased from Invitrogen (Carlsbad, CA, USA)
unless otherwise stated. Both HS293 and HS346 were used in each
of the experiments performed and no differences between these
lines were observed.
Ab preparation and ThT fluorescence assay
To obtain fibrillar forms of Ab1–40 and Ab1–42, the Ab peptides
(Sigma, St. Louis, MO, USA) were dissolved in PBS and incubated
with gentle shaking for 72 h at 37uC. Oligomeric Ab species
(AbO) were prepared by dissolving 1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP)-pretreated Ab1–40 or Ab1–42 (rPeptides, Bogart,
GA, USA) in DMSO, followed by sonication and filtration.
Aliquots were then stored at 280uC until time for usage.
Thioflavine T fluorescence assays were performed according to
a previously described protocol [24]. Briefly, AbO1–40 (100 nM,
5 mM) or AbO1–42 (100 nM, 1 mM) were mixed with NPM, and
thioflavine T and sodium azide (Sigma, St. Louis, MO, USA) were
added to a final concentration of 1 mM and 0.02%, respectively.
Thioflavine T fluorescence of samples was measured using an
excitation wavelength of 450 nm and an emission wavelength of
485 nm at 37uC in 15 min intervals over a time period of 72 h
using an Infinite M1000 plate reader (Tecan, Ma ¨nnedorf,
Switzerland). To verify the aggregation forms of AbO in the
experimental conditions used, HFIP-pretreated and sonicated
Ab1–40 and Ab1–42 (100 nM, 5 mM and 100 nM, 1 mM, respec-
tively) were incubated in NPM for 72 h at 37uC. Samples were
analyzed by Western blotting as described by Stine [25]. Briefly,
unheated samples in Laemilli buffer were separated by SDS/
PAGE, blotted onto PVDF membranes and then blocked in 5%
non-fat milk. The membranes were incubated at 4uCo v e r n i g h t
with mouse anti-4G8 (1:1000, Covance, Dedham, MA, USA),
washed and then incubated with horseradish peroxidase-conju-
gated secondary antibody (donkey anti-mouse IgG; 1:2000, Santa
Cruz Biotechnology) for 1 h. Signals were visualized by incubation
b-Amyloid 1-42 Oligomers Impair Neurogenesis
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reagents and exposure to Hyper Performance Chemiluminescence
film (GE Healthcare, Buckinghamshire, UK).
RNA isolation and real-time qPCR
RNA samples were isolated from hES cells differentiated for
28–35 days with TRI Reagent solution (Sigma, St. Louis, MO,
USA) and 0.5 mg RNA was reverse transcribed by using a High
Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City,
CA, USA) (at 37uC for 60 min followed by 95uC for 5 min). Real-
time qPCR was performed by using either SYBR Green I dye or
TaqMan probe-based detection in a Step One Plus Real-Time
PCR system (Applied Biosystems) according to the manufacturer’s
instructions. For the SYBR Green system, PCRs were performed
at 95uC for 10 min, followed by 40 cycles at 95uCf o r1 5sa n d
60uC for 60 s. The specificity of each amplified product was
confirmed using a dissociation curve analysis. For TaqMan probe-
based detection, PCRs were performed at 50uCf o r2m i n ,9 5 uC
for 10 min, followed by 40 cycles at 95uC for 15 s and 60uCf o r
60 s. The TaqMan gene expression assays and primer sequences
used in this study are listed in Table S1 and Table S2, respectively.
All PCR reagents were purchased from Applied Biosystems.
Cyclophilin A was used as an endogenous control and mRNA
expression, relative to that in untreated cells (control), was
quantified by the 2
-DDCt method [23] using StepOne software
v2.1 (Applied Biosystems). Prior to gene expression quantification,
the primers were optimized to ensure close to 100% amplification
efficiency.
Immunocytochemistry
hES cells differentiated on poly-D-lysine- and laminin-coated
cover slips were fixed with 4% paraformaldehyde at 4uC for
20 min, and thereafter permeabilized in blocking buffer, (3%
normal donkey serum in PBS containing 0.05% Triton X-100) and
incubated overnight at 4uC with the following antibodies; goat
polyclonal IgG anti-human glutamic acid decarboxylase 67 (GAD-
67; 1:100, Santa Cruz Biotechnology, Heidelberg, Germany), goat
polyclonal anti-human choline acetyltransferase (ChAT; 1:100,
Millipore, Temecula, CA, USA), mouse IgG2a monoclonal anti-
human beta III-tubulin (1:250, Abcam, Cambridge, UK), rabbit
polyclonal anti-microtubule-associated protein 2 (MAP2) (1:250,
Millipore, Temecula, CA, USA) and rabbit polyclonal anti-human
glial fibrillary acidic protein (GFAP; 1:250, Dako, Glostrup,
Denmark). Following 365 min washes in PBS, secondary antibod-
ies conjugated with Alexa Fluor (AF 488 donkey anti-goat, AF 594
donkey anti-mouse or AF 488 donkey anti-rabbit, 1:500; Molecular
probes, Eugene, OR, USA) were added for a 1 h incubation period
at RT in the dark. In addition, control experimentswere performed
where the primary antibody was substituted with blocking buffer to
establish the specificity of the secondary antibodies. The cells were
then washed with PBS (365 min) and mounted with Vectashield
with DAPI for fluorescent microscopic analysis under a Nikon
E800 microscope. Three to six random fields were counted in each
experiment (.500 cells counted). Quantification was determined
by counting the number of immunoreactive (ir) cells in each
experiment divided by the total number of cells (DAPI-ir cells) in
the same experiment.
Cell proliferation assays
For proliferation assays, neurospheres from hES cells were
dissociated with dispase (0,1 mg/ml) for 10 min at 37uC. The cells
were plated in a 96-well tissue culture plate (25 000 cells/well)
24 h prior to the administration of NGF (50 ng/ml, Invitrogen)
and oligomeric or fibrillar Ab1–40 and Ab1–42 (10 pM, 1 nM,
10 nM, 100 nM, 1 mMo r5mM, rPeptide, Bogart, GA, USA or
Sigma, St. Louis, MO, USA). Measurements of cell proliferation
were performed after 14 days of NGF and Ab treatment, using a
Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) incorpora-
tion assay according to the manufacturer’s instructions (Roche,
Mannheim, Germany).
Caspase 3/7 measurements
For caspase measurements, dissociated hES cell-derived neuro-
spheres were plated in a 96-well black-walled tissue culture plate
(20 000 cells/well) 24 h prior to administration of NGF (50 ng/ml,
Invitrogen, Carlsbad, CA, USA), oligomeric or fibrillary Ab1–40 or
Ab1–42 species (10 pM, 1 nM, 10 nM, 100 nM, 1 mMo r5mM,
rPeptide, Bogart, GA, USA). Caspase measurements were carried
out 7 days after NGF and Ab treatment using a Caspase-Glo 3/7
assay (Promega, Madison, USA) according to the manufacturer’s
instructions.
Electrophysiological measurements of intracellular
calcium
Human ES cells treated each week with NGF (50 ng/ml),
AbO1–40 (100 nM) or AbO1–42 (1 mM) and differentiated for 28–
35 days in vitro were maintained in culture medium and then
loaded with the calcium-sensitive dye Fluo-3 AM (5 uM;
Molecular Probes, Eugene, OR) for 60 min in Krebs-Ringer-
HEPES (KRH) buffer (pH 7.4) containing pluronic acid (0.02%)
and incubated at 37uC in the dark. The hES cell-derived neurons
were stimulated with ACh (10 mM) and KCl (5 mM). Measure-
ments of [Ca
2+]i were also performed on untreated cells following
acute exposure to oligomeric Ab1–40 and Ab1–42 (10 pM, 1 nM,
10 nM, 100 nM and 1 mM). The fluorescence measurements were
performed using an Andor DU-860 electron multiplying (EM)
CCD camera (Andor, Belfast, Ireland). To minimize the noise,
EM gain was maintained at 10% and the CCD sensor was cooled
to 280uC. The specimen was excited with a 470 nm LED array
(Roithner Laser, Vienna, Austria) and the emission light was
filtered with a 505 nm low-pass filter. Images were captured using
custom-made software (‘KiaFluor’) that runs in Labview (National
Instruments, USA). For each measurement, samples were exposed
to light for 6 s and bleaching was negligible (below 5%) even after
10 exposure cycles. Kinetic imaging series were analyzed in
Matlab (Mathworks, USA) following custom-made routines. Cells
were considered to respond to the chemical stimuli if the mean
fluorescence increased by .10% and if they also exhibited a fast,
spontaneous calcium transient, characteristic for neurons [24].
The authors welcome any requests for software copies.
Activation of the Akt cell-survival signaling pathway
To determine whether the effects of Ab oligomers on neuronal
differentiation were mediated by the involvement of phosphoino-
sitide 3-kinase (PI3-K)-dependent activation of the Akt signaling
pathway, hES cells that had differentiated for 28–35 days were
stimulated with NGF (50 ng/ml) for 30 min or AbO1–40 (5 mM) or
AbO1–42 (1 mM) for 60 min and then lysed in cold tris buffer saline
(TBS) containing 1% Triton X-100, protease inhibitors and
phosphatase inhibitors. Protein concentrations were determined
using a DC protein assay kit (Biorad, Stockholm, Sweden). For
inhibition of PI3-K signaling, cells were exposed to the inhibitor
LY294002 (10 mM, Sigma) 5 h prior to stimulation with NGF or
Ab. Samples were denaturated and 20 mg protein was loaded and
separated by SDS/PAGE and then blotted onto PVDF mem-
branes and blocked in 5% bovine serum albumin. The membranes
were incubated at 4uC overnight with primary antibodies: rabbit
b-Amyloid 1-42 Oligomers Impair Neurogenesis
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Akt (1:1000, Cell Signaling Technology, Danvers, MA, USA) and
rabbit polyclonal anti-b-actin (1:2000, Abcam). After washing, the
membranes were incubated with horseradish peroxidase-conju-
gated secondary antibody (donkey anti-rabbit IgG or donkey anti-
mouse IgG; 1:2000, Santa Cruz Biotechnology). Signals were
visualized by incubation of the membranes in ECL Plus reagents
and exposure to Hyper performance Chemiluminescence film.
The films were scanned and the optical density of each band,
normalized to that of b-actin, was analyzed by using the public
domain National Institutes of Health Image J software.
Statistical analysis
Results are expressed as mean 6 SD from 3–4 independent
experiments and analyzed by means of unpaired Student’s t-test,
the Z-test for differences in proportion, or one-way ANOVA
followed by Dunnett’s post hoc test, as appropriate using GraphPad
Prism 5.0 (GraphPad Software, Inc. La Jolla, CA, USA). Results
from real time qPCR measurements are expressed as mean fold
change 6 S.E. fold change and the DDCt-values from 3–6
independent experiments were analyzed by means of unpaired
Student’s t-test (GraphPad Prism 5.0). Values of p,0.05 were
considered significant.
Results
Treatment of hES cells with nerve growth factor
promotes differentiation of basal forebrain cholinergic
neurons
The gene expression for glial and neuronal markers with
emphasis on the cholinergic system was assessed after treatment
with NGF in hES cell-derived neurons by real time qPCR and
quantified relative to control (untreated) cells using the DDCt
method [23]. Following 28–35 days of differentiation, hES cells
expressed glial fibrillary acidic protein (GFAP), the neuronal
suppressor genes Notch2 and hairy and enhancer of split (Hes1) as
well as the late neuronal marker microtubule-associated protein 2
(MAP2) (Figure 1). Furthermore, the differentiated cells expressed
transcripts for the cholinergic receptors p75 neurotrophic receptor
(p75
NTR), neurotrophic tyrosine kinase receptor type 1 (TrkA), the
a4 and a7 nicotinic acetylcholine receptor (nAChR) and the
M3 muscarinic acetylcholine receptor (mAChR) (Figure 1). In
addition, we detected expression of the cholinergic enzymes
choline acetyltransferase (ChAT) and vesicular acetylcholine
transporter (VAChT) (Figure 1). Cells exposed to NGF during
differentiation showed an increased gene expression of ChAT (1.7-
fold increase, p,0.05).
Figure 1. NGF promotes the differentiation of hES cells into cholinergic and GABAergic neurons. Expression of neuronal and glial
markers following NGF (50 ng/ml) treatment in hES cells differentiated for 28–35 days in vitro. (A, B) Gene expression levels were assessed by real-
time qPCR and normalized to those of cyclophilin. Values are expressed as mean fold change (6 S.E.) from 3–6 independent experiments. *p,0.05
compared with controls (unpaired Student’s t-test). (C) The proportion of cells expressing the choline acetylcholine transferase (ChAT) or glutamic
acid decarboxylase GAD67 following treatment with NGF. Values are expressed as mean 6 SD (.500 cells counted). *p,0.05 compared with controls
(unpaired Student’s t-test). (D) Immunostaining of ChAT (green) and neuronal marker bIII-tubulin (red) in untreated cells and in (E) NGF-differentiated
hES cells (at 20x). Nuclei were stained with DAPI (blue).
doi:10.1371/journal.pone.0015600.g001
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hES cell-derived neurons, we examined the number of ChAT
+
cells co-expressed with the neuronal marker bIII-tubulin
+ cells by
using immunocytochemistry (Figure 1C–E). Following NGF
treatment, the proportion of neurons expressing ChAT was
increased (25.064.7%) compared with untreated cells (17.56
6.4%) (Figure 1C). A significant increase in the number of
glutamic acid decarboxylase GAD67
+ cells was also observed in
NGF treated hES cells (45.2614.6%) compared with untreated
cells (34.865.2%, p,0.05) (Figure 1C).
Basal forebrain identity of cholinergic hES cell-derived
neurons
To characterize the subregional identity of hES cells treated with
NGF, we analyzed the expression of transcription factors known to
play a key role in regulating the development of BFCNs at 0, 3, 9, 20
and 28 days of differentiation. We observed a high expression of the
transcription factor Nk2-homebox 1 (Nkx2-1) that decreased during
28 days of differentiation. The expression of the LIM-homebox gene,
Lhx8 increased as hES differentiation progressed (Figure S2). The
cholinergic phenotype of the derived neurons was also confirmed by
an increased ChAT expression after NGF exposure during
differentiation, while a decreased expression of ChAT was observed
in the untreated cells (Figure S2). Interestingly, the peak in Lhx8
expression at 9 days of differentiation coincided with the increase in
ChAT detection in NGF treated cells but not in control cells,
suggesting that NGF is an important inductive factor for promoting
the development of BFCNs. Furthermore, exposure of hES cells to
NGF during 28 days of differentiation significantly increased (4.2-
fold, p,0.05) the expression of the LIM-homeobox gene Islet-1 (Isl1)
(Figure1).Surprisingly,transcriptsforChAT,Lhx8andNkx2-1were
also detected at day 0 of differentiation, and at later stages of
differentiation in the absence of NGF, suggesting a default induction
for hES cells to differentiate into telencephalic neurons (Figure S2).
Effects of oligomeric Ab1–40 and Ab1–42 on hES cell
differentiation
The permanence of oligomeric Ab species throughout the
experiments was assessed by means of a thioflavine T fluorescence
assay (Figure S3A). Western blotting analysis was also performed as
previously described [25], which confirmed that HFIP-pretreated
Ab1–40 and Ab1–42 was converted from monomers to oligomeric
species during our experimental conditions (Figure S3B).
To study the effects of oligomeric Ab (AbO) on hES cell
cholinergic neuronal differentiation we examined the gene expres-
sion profile following exposure to AbO1–40 (100 nM, 5 mM) and
AbO1–42 (100 nM, 1 mM). A high concentration of Ab1–42 (5 mM)
was toxic to the cells, affecting their morphology and treatment at
this high concentration was discontinued (data not shown). Exposure
to AbO1–40 (5 mM) revealed a significant increase in the expression
of the a4 nAChR subunit (1.6-fold, p,0.05). There was also a
significant decrease in expression of ChAT (p,0.01 and p ,0.001
Figure 2. Gene expression of hES cells exposed to Ab1–40 and Ab1–42 oligomers. Expression of neuronal and glial markers following (A)
AbO1–40 (100 nM or 5 mM) and (B) AbO1–42 (100 nM or 1 mM) treatment of hES cells differentiated 28–35 days in vitro. Values are expressed as mean
fold change (6 S.E.) from 3–6 independent experiments. *p,0.05, **p,0.01, ***p,0.001 (unpaired Student’s t-test).
doi:10.1371/journal.pone.0015600.g002
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p75
NTR (p,0.05 and p,0.01 for 100 nM and 5 mM, respectively)
following Ab1–40 treatment (Figure 2A). Immunocytochemical
analyses of the number of bIII-tubulin
+ cells following AbO1–40
(5 mM)exposure(84.065.5%)weresimilartothoseinuntreatedcells
(89.064.3%) (Figure 3F). Similarly, the proportion of GFAP
+ cells
did not differ after AbO1–40 exposure (15.066.1%) compared with
untreated cells (11.064.3%) (Figure 3F). However, we found a
significant decrease in the number of ChAT
+ cells following
exposure to Ab1–40 (5 mM) (4.363.8%, p,0.05) compared with
untreated cells (17.566.4%) (Figure 3G), that correlated with a
decrease in ChAT gene expression.
Treatment with AbO1–42 (1 mM) resulted in a significant
increase in gene expression of the a4 nAChR (2.7-fold, p,0.05)
and a7 nAChR (1.6-fold p,0.05) subunits as well as a significant
decrease in gene expression of the tyrosine kinase receptor (TrkA)
(p,0.05 for both 100 nM and 1 mM) (Figure 2B). Immunocyto-
chemical staining revealed that AbO1–42 (1 mM) treatment did not
alter neither the proportion of bIII-tubulin
+ cells (79.8623.0%)
nor the proportion of GFAP
+ cells (17.9618.4%) compared with
untreated cells (89.0%64.3% and 11.064.3% for bIII-tubulin
+
and GFAP
+ cells, respectively) (Figure 3F), but significantly
decreased the number of MAP2
+ cells (11.560.7%, p,0.01)
compared with untreated cells (25.161.0) (Figure S4). Further, a
decrease in the number of ChAT
+ cells was observed in cells
treated with AbO1–42 (100 nM) (3.066.4%, p,0.01) as well as
AbO1–42 (1 mM) (10.162.0%, p.0.05) compared with untreated
cells (17.566.4%) (Figure 3G).
Effects of fibrillar Ab1–40 and Ab1–42 on hES cell
differentiation
Next, we examined the effects of fibrillar Ab (Abf) (100 nM,
5 mMo fA b1–40) and (100 nM, 1 mMo fA b1–42) on hES cell
differentiation. The hES cells exposed to Abf1–40 (Ab 100 nM and
5 mM, respectively) demonstrated an increased gene expression of
p75
NTR (10.1-fold, p,0.05, 9.1-fold, p,0.01, respectively), GFAP
(15.4-fold and 12.1-fold, p.0.05, respectively), butyrylcholine
esterase (BuChE) (3.7-fold, p,0.05, respectively), and Hes1 (1.8-
fold and 1.5-fold, p.0.05, respectively) (Figure 4). In addition,
treatment with Abf1–40 resulted in a significant increase in a7
nAChR subunit gene expression (1.8-fold, p,0.01, for both
100 nM and 5 mM), and a significant decrease in TrkA (p,0.01,
5 mM) gene expression (Figure 4). Interestingly, no ChAT gene
expression was detected following Abf1–40 (100 nM, 5 mM)
exposure (Figure 4B). Consistent with the real time qPCR data,
the proportion of GFAP
+ cells increased following Abf1–40 (5 mM)
exposure (40.0610.3%, p,0.001) compared with untreated cells
(11.062.5%), while in contrast, a decrease in the number of bIII-
tubulin
+ cells (57.068.5%, p,0.001) was observed in comparison
with untreated cells (89.062.5%) (Figure 3F).
The analysis of gene expression in cells treated with Abf1–42
revealed significant increases in both GFAP (8.3-fold, p,0.001, Ab
1 mM) and MAP2 (1.4-fold, p,0.05, Ab 100 nM) and a slight
increase for the a7 nAChR transcript (2-fold, p.0.05, Ab 100 nM
and 1 mM) (Figure 4A). The observed increase in GFAP gene
expression was in line with the observation of a significant increase
in the proportion of GFAP
+ cells (36.3617.1%, p,0.05) following
Abf1–42 (1 mM) exposure compared with untreated cells
(11.064.3%), whereas a significant decrease in bIII-tubulin
+ cells
(58.5616.8% p,0.01) was observed compared with control
(89.064.3%) (Figure 3F).
Effects of fibrillar and oligomeric Ab1–40 and Ab1–42 on
hES cell proliferation
b-amyloid has previously been reported to have differential
effects on hES cell proliferation depending on the aggregation
Figure 3. Fibrillar Ab1–40 and Ab1–42 induces glial differentiation of hES cells. Immunocytochemical staining for neuronal and glial markers
following NGF, AbOo rA bf exposure in hES cells differentiated for 28–35 days in vitro. (A) Immuno- reactivity for bIII-tubulin (red) and glial fibrillary
acidic protein, GFAP (green) in untreated cells, (B) AbO1–40 (5 mM) exposed hES cells, (C) Abf1–40 (5mM) exposed hES cells, (D) AbO1–42 (1 mM) exposed
hES cells and (E) Abf1–42 (1 mM) exposed cells (at 20x). Nuclei were stained with DAPI (blue). (F) The proportion of cells expressing bIII-tubulin or GFAP,
following Ab treatment. Fibrillar Ab1–40 (5 mM) and Ab1–42 (1 mM) decreased the expression of bIII-tubulin. (G) ChAT
+ cells following AbO1–40 (5 mM) or
Ab1–42 (100 nM or 1 mM) exposure (.500 cells counted). Values are expressed as mean 6 SD from three independent experiments. *p,0.05,
**p,0.01 and ***p,0.001 compared with controls (unpaired Student’s t-test).
doi:10.1371/journal.pone.0015600.g003
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species studied here were mitogenic by exposing the cells to
fibrillar or oligomeric Ab1–40 and Ab1–42 for 14 days in vitro, and
thereafter used a cell proliferation colorimetric assay to measure
BrdU incorporation. AbO1–40 treatment increased the cell
proliferation significantly at 100 nM and 5 mM concentrations
(p,0.001 and p,0.05, respectively), compared to untreated cells
(Figure S5A). There was no significant increase in proliferation
observed following treatment with neither AbO1–42,A bf1–40 nor
Abf1–42 (Figure S5).
Caspase 3 and 7 measurements following exposure to
oligomeric and fibrillar Ab
To investigate whether exposure of hES cells to Ab could lead
to activation of downstream apoptotic signaling events, caspase 3/
7 activity measurements were carried out. We observed that only
low concentrations (100 nM) of Abf1–40,A bO1–42 and Abf1–42
increased caspase 3/7 activity significantly (p,0.01, p,0.001,
p,0.05, respectively) after 7 days exposure (Figure S5). No
significant changes in caspase 3/7 activity were observed in hES
cells exposed to AbO1–40 (Figure S5).
Characterization of functional properties of hES cell-
derived neurons
Functional properties of the hES cell-derived neurons were
evaluated by [Ca
2+]i electrophysiological recordings (bulk loading
cultures with Fluo-3 indicator). Cells were considered to respond
to the stimuli if there was an increase in fluorescence (DF/F0)o f
.10%. All cells that responded to the stimuli (.10% increase in
fluorescence) also exhibited a fast, spontaneous calcium transient,
characteristic for neurons (representative example shown in
Figure 5B) [24]. ACh (10 mM) did not evoke any [Ca
2+]i increase
in the untreated cells. We observed an increase in [Ca
2+]i
following depolarization of the cells with KCl (5 mM) in 17.9% of
the untreated cells (Figure 5). The hES cell-derived neurons
exposed to NGF during differentiation exhibited significant
increases in the number of cells responding to both ACh
(24.1%, p,0.01) and KCl (51.7%, p,0.01) compared with
untreated cells, reflecting an increase in the proportion of neurons
expressing cholinergic receptors as well as voltage-gated Ca
2+
channels (VGCCs) (Figure 5).
To investigate immediate effects of Ab on [Ca
2+]i in hES cell-
derived neuronal populations, we exposed untreated cells which
Figure 4. Gene expression of hES cells exposed to fibrillar Ab1–40 and Ab1–42. Expression of neuronal and glial markers, following Abf1–40
(100 nM or 5 mM) and Abf1–42 (100 nM or 1 mM) treatment in hES cells differentiated for 28–35 days in vitro (A, B). Values are expressed as mean fold
change (6 S.E fold change), from 3–6 independent experiments, *p,0.05, **p,0.01, ***p,0.001 (unpaired Student’s t-test).
doi:10.1371/journal.pone.0015600.g004
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well as to Ab1–42. The acute application of either AbO1–40 or
AbO1–42 (10 pM, 1 nM, 10 nM, 100 nM and 1 mM) to hES cells
failed to evoke a .10% increase in fluorescence in our Ca
2+-
imaging experiments (data not shown). The presence of functional
cholinergic receptors and VGCCs on neuronal cells derived from
hES cells treated with AbO1–40 and AbO1–42 during 28–35 days of
differentiation was also evaluated. In cells exposed to AbO1–40, the
proportion of cells responding to ACh (25.7%) was significantly
increased (p,0.01) compared with untreated cells (Figure 5).
Depolarization with KCl (5 mM) increased [Ca
2+]i in a larger
population of hES-derived neuronal cells exposed to AbO1–40
(31.4%) compared with controls (17.9%) (Figure 5). In contrast, in
the AbO1–42-treated cells, the proportion of cells responding to
KCl (12.1%) was decreased compared with controls (17.9%).
However, a small proportion of these cells did respond to ACh
(3.0%), which was not detected in the untreated cells (Figure 5).
NGF promotes cholinergic neuronal differentiation
through the PI3-K/Akt pathway
To examine the signaling mechanisms involved during hES cell
differentiation following NGF and AbO exposure, Akt phospor-
ylation was analyzed since the phosphoinositide-3-kinase (PI3-K/
Akt) signaling pathway has been implicated in promoting neuro-
nal survival and differentiation [27]. Differentiated hES cells
stimulated with NGF (50 ng/ml) or AbO1–40 (5 mM) induced
phosphorylation of Akt (Figure 6). NGF induced the highest p-Akt
expression (1.7460.74 relative to controls, p,0.01) that was
inhibited in the presence of the PI3-K inhibitor LY294002
(10 mM) (Figure 6). On the other hand, the increased expression of
p-Akt (1.6661.54 relative to controls), following exposure to
AbO1–40 (p.0.05) was not inhibited by LY294002 (Figure 6).
Cells stimulated with AbO1–42 (1 mM) did not induce any
significant changes in p-Akt expression (0.9560.16) (Figure 6).
Discussion
Elucidation of the molecular signals governing cholinergic
development and dysfunction is essential for the design of novel
drugs that could stimulate regeneration and support neuroprotec-
tive mechanisms in the brain of patients afflicted with AD.
The generation of new neurons in the adult brain may be
associated with the rewiring of the brain and regulation of
cognitive functions and these processes are most likely influenced
by disease pathology. Therefore, a further understanding of how
AD-related physiological and pathological conditions alters the
behavior of stem cell reservoirs residing in neurogenic regions in
the brain is crucial for the implementation of future regenerative
strategies.
BFCNs are dependent on NGF for the maintenance of their
cholinergic phenotype and their cholinergic synaptic integrity [6].
NGF has been shown to regulate dendritic growth, axon guidance,
long-term potentiation (LTP), synaptic plasticity and neurotrans-
mitter release [28]. An imbalance in NGF axonal transport and
loss of its high-affinity receptor TrkA has been observed in both
early and late stages of AD [29]. In clinical studies, intracer-
ebroventricular NGF administration in AD patients demonstrated
an increase in the number of
11C-nicotine binding sites measured
by PET [30] and a reduced rate of cognitive decline [31]. We
recently reported that neurotrophic factors, including NGF,
modulate the fate of hES cells and promote the differentiation
into BFCNs [12].
In the present study, we further characterized and quantified
the expression of neuronal and cholinergic markers following
exposure of hES cells to NGF during their differentiation by
means of quantitative gene expression profiling and fluorescent
immunocytochemistry. Here, we report that NGF treatment
induces an increase in the number of neurons expressing a
cholinergic phenotype in agreement with our previous observa-
tions [12]. Furthermore, we observed that NGF influences
neuronal phenotypic expression in hES cultures and gives rise to
both cholinergic as well as GABAergic neurons. Intriguingly,
transcripts for the homeobox genes Nkx2-1, and Lhx8 as well as
ChAT were observed at day 0 of differentiation, suggesting a
default forebrain identity of the two lines of hES cells used in this
study. These observations concur with an earlier study reporting
Figure 5. Characterization of functional properties of hES cell-
derived neurons. Fluorescence imaging with the calcium indicator
Fluo-3 in hES cell-derived neurons, differentiated for 28 days in vitro. (A)
The top-left panel is a differential interference contrast (DIC)
photomicrograph showing all the cells in a field of oligomeric Ab1–40
(100 nM) exposed hES cells. Fluorescence images of cell bodies in
control conditions (top-right), 5 min after ACh (10 mM) (bottom-left),
and 5 min after the addition of 5 mM KCl (bottom-right). Images are
shown with arbitrary pixel intensity (0=100% black and 255=100%
white), scale bar=50 mm. Arrows indicate examples of cell bodies that
showed fluorescence changes of .10% DF/F0. (B) Summary showing
the percentages of cell bodies that reacted with more than a 10% DF/F0
increase in fluorescence in response to ACh (10 mM) (white bars) and
5 mM KCl (black bars), with different pre-conditions (control, NGF
(50 ng/ml), AbO1–40 (100 nM) and AbO1–42 (1 mM)). Inset shows an
example of a fast spontaneous calcium transient recorded in a neuron
from NGF (50 ng/ml) treated hES cells in the presence of ACh (10 mM).
doi:10.1371/journal.pone.0015600.g005
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very early stage during embryonic development [32]. It has been
suggested that the early expression of a cholinergic system in both
neuronal and non-neuronal cells is indicative of a regulatory
function of this system, that mediates basic cellular functions like
proliferation, gene expression, differentiation, cytoskeletal mobil-
ity, migration, and secretion [32]. Considering these many
different roles, it is likely that the cholinergic system will not
function in the same manner throughout embryonic development,
taking over its main role within the nervous system only at later
stages.
The PI3-K/Akt pathway has been implicated in promoting
neuronal survival, proliferation and differentiation, synaptogenesis
as well as translocation of VGCCs to the plasma membrane. It has
earlier been reported that NGF induces the expression of
cholinergic markers via the PI3-K/Akt pathway [33]. Here, we
demonstrate that NGF induced an increase in phospho-Akt, which
was inhibited in the presence of the PI3-K inhibitor LY294002.
Thus, these findings indicate that NGF mediates differentiation
and cell survival in hES cells by activating this pathway.
Furthermore, we showed that NGF significantly increases the
number of functional neurons expressing cholinergic receptors and
VGCCs, indicating that NGF is required not only for maintaining
a cholinergic phenotype, but also for the maturation of newly
differentiated neurons.
The pathophysiological environment in the AD brain may
present limitations for the use of therapies intending to stimulate
neurogenesis, and we have earlier proposed that modulation of the
microenvironment with disease-modifying drugs may augment
neuroregenerative processes [34]. PET amyloid imaging studies in
patients with mild cognitive impairment and mild AD have
demonstrated that the deposition of fibrillar Ab is one of the early
initiating pathogenic events in the disease process [35]. However,
in recent years, the focus has shifted towards oligomeric forms of
Ab which are also present in the AD brain. These soluble forms of
Ab are suggested to be the most toxic, as they block LTP in
hippocampal slices, impair synaptic calcium homeostasis and
induce cell death in cultured neurons [8,36]. A previous study
demonstrated that hES cells transplanted into the developing
mouse brain can differentiate into neural lineages and generate
mature, functional human neurons that successfully integrate into
the adult mouse forebrain [37]. Although these findings hold great
promise for cell-replacement therapy, not much is known about
how amyloid pathology in AD may influence the differentiation
and function of stem cell-derived neurons. To address this, we
systematically investigated the effects of both oligomeric and
fibrillar forms of Ab1–40 and Ab1–42 on hES cell-derived neuronal
populations in vitro, as these may have relevance with regards to
synaptic plasticity in the brain. A dose-dependent increase in
proliferation as measured by BrdU incorporation was observed in
hES cells treated with oligomeric and fibrillar Ab1–40 and Ab1–42.
Surprisingly, immunocytochemical staining revealed the presence
of .75% bIII-tubulin
+ cells in cultures exposed to Ab1–42 and
Ab1–40 oligomers, a proportion that did not differ from that of
untreated cells. However, the number of MAP2 positive cells (late
neuronal marker) was significantly decreased following oligomeric
Ab1–42 exposure, suggesting a decrease in the capacity of these
cells to differentiate into mature neurons.
It has earlier been postulated that Ab may transiently promote
the generation of nonfunctional neurons from neural stem cells
[38]. In the present study, we determined whether the hES cell-
derived neurons exhibited functional cholinergic receptors and
VGCCs. We found that Ab1–40 oligomers increased the number of
functional neurons but suppressed cholinergic neuronal differen-
tiation, whereas in contrast, Ab1–42 oligomers decreased the
proportion of functional neurons as well as suppressed neuronal
cholinergic differentiation. The impaired functional response was
not due to apoptotic events since no significant increase in caspase
3/7 activity was detected at similar concentrations. Moreover, we
demonstrated that both fibrillar
Ab1–40 and Ab1–42 promote glial differentiation in hES cells,
since significant increases in the expression of glial markers GFAP
and the neuronal suppressor gene Hes1 were detected. An
increased a7 nAChR expression was also observed in hES cells
treated with fibrillar Ab1–40, which most likely reflects an up-
regulation of a7 nAChRs on astrocytes in response to increased
amyloid deposition in AD, in concurrence with a previous
observation in autopsy brain tissue from AD patients [39].
The presence of nAChRs and mAChRs are not exclusively
located on cholinergic neurons, but these are also expressed on
Figure 6. NGF-induced phosphorylation of Akt is mediated through the PI3-K signaling pathway. To measure the levels of
phosphorylated Akt (p-Akt) mediated through stimulation of the PI3-K signaling pathway, hES cells were treated with the PI3-K inhibitor LY294002
(10 mM) 5 h prior to stimulation with NGF (50 ng/ml) or AbO1–40 (5 mM). Cell lysates were analyzed by Western blotting, using phospho-specific
antibodies, and b-actin served as a loading control. (A) Following stimulation with NGF or AbO1–40, p-Akt levels were 1.7460.74 and 1.6661.54
relative to controls, respectively. Induction of p-Akt by NGF was inhibited by LY294002. However, the AbO1–40-dependent phosphorylation of Akt was
not inhibited by LY294002. Values are expressed as mean 6 SD (relative to controls), *p,0.05 (unpaired Student’s t-test). (B) Representative
immunoblots of p-Akt, total Akt and b-actin.
doi:10.1371/journal.pone.0015600.g006
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the increase in the number of neurons responding to ACh
following oligomeric Ab1–40 exposure. Ab may also have a
physiological role in the brain and we suggest that it is also possible
that oligomeric Ab1–40 augments the number of functional
cholinergic receptors as a compensatory mechanism, whereas
Ab1–42 oligomers may specifically promote differentiation of hES
cells to non-functional neurons. Previous studies investigating the
role of Ab on neurogenesis have provided conflicting results. Data
in support of both enhanced neurogenesis [16,17] as well as
neurotoxic effects [41] have been reported. The different
experimental conditions applied in these earlier reported studies
and our present study, including the aggregation states of Ab as
well as the different source of stem cells (fetal or adult as well as
human or murine) could account for the discrepant findings.
Since oligomeric Ab did not alter the number of bIII-tubulin
positive cells, we investigated whether oligomeric Ab exposure
stimulated PI3-K/Akt signaling, since this pathway is implicated in
promoting neuronal survival and differentiation. We observed an
increase in protein levels of phospho-Akt following exposure to
Ab1–40 oligomers, which was not inhibited by LY294002. These
results suggest that the Ab1–40-induced phosphorylation of Akt in
hES cell-derived neurons is not mediated by the PI3-K pathway and
occurs through yet unknown mechanisms. A recent study reported
that intracellular Ab1–42 oligomers inhibit PI3-K/Akt signaling in
neuronal cells in culture [42]. However, we did not observe any
change in phospho-Akt following stimulation with Ab1–42 oligomers
in our present study.
In conclusion, our current findings indicate that factors governing
neurogenesis in the brain depend on the state of aggregation and the
concentration of Ab species. In addition, our data supports the idea
that latent progenitor reservoirs existing in neurogenic regions of the
brain have a diminished capacity for supporting neurogenesis in AD.
This may result from reduced concentrations of trophic factors,
impaired trophic metabolic signaling and as a consequence of Ab
oligomers transiently promoting the generation of immature neurons,
while Abfibrillardeposits may promote the differentiation towards cell
types associated with inflammatory lesions. Efforts to boost the brain
with trophic support as well as the development of inhibitors that
target Ab-induced signaling pathways or specific aggregation forms of
Ab, in particular Ab1–42 oligomers, can thus promote the survival and
maturation of functional stem cell-derived neurons in AD.
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